Warning Letter Roundup & Recap – Sept. 5, 2017
Executive Summary
US FDA broke a six-week dry spell by finally posting a handful of device-related warning letters online this week, touching on problematic complaint handling practices, marketing of unapproved devices and a bevy of quality systems violations. All six letters were written by the agency's device center.